The consensus is that GHK-Cu can enhance results, but it usually complements other therapies (like vitamin supplementation, topical agents, or healthy lifestyle) rather than serving as a standalone fix
Testing is rarely the first step in a wellness journey, but it becomes valuable when you need to "clarify the why" behind persistent symptoms
GLP-1 drugs mimic this hormone activity, binding to GLP-1 receptors and stimulating insulin release
The goal should always be total well-being, not aesthetics
Particularly noteworthy is that in patients with both type 2 diabetes and MASLD, after 24 weeks of treatment with a 10 mg dose of efinopegdutide, liver fat content reduced by 72.7%, a result that is superior to the 42.3% reduction achieved with a 1 mg dose of semaglutide, despite a similar overall weight loss being observed with the two interventions
These included age, sex, smoking status, hypertension status, Type 2 diabetes status, peripheral artery disease, hyperlipidemia, chronic kidney disease and a history of heart attack or a history of heart failure
